Heterogeneity of protein kinase C ?2expression in lymphoid malignancies
- 1 April 2007
- journal article
- Published by Wiley in Histopathology
- Vol. 50 (5), 561-566
- https://doi.org/10.1111/j.1365-2559.2007.02666.x
Abstract
Protein kinase C (PKC) beta is an important regulator of lymphoid survival and its expression has been shown to be altered in lymphomas. The aim was to determine the expression of PKC beta(2) in various subtypes of lymphoproliferative diseases by immunohistochemistry. One hundred and forty archival samples representing various subtypes of lymphoproliferative diseases were analysed. Certain subtypes, such as mantle cell, lymphocytic or follicular lymphoma, were found to express PKC beta(2) in > 90% of the samples. In follicular lymphomas, the follicular lymphomatous areas were constantly labelled, whereas residual germinal centres remained negative. In follicular hyperplasia, PKC beta(2)+ cells were found in the mantle and marginal zones. Most angioimmunoblastic T-cell lymphomas, lymphoblastic T-cell lymphomas and marginal zone/mucosa-associated lymphoid tissue (MALT) lymphomas were labelled with anti-PKC betaII antibody, but the pattern of expression was more heterogeneous in these subtypes. A minority of diffuse large B-cell lymphomas were stained and most plasma cell malignancies were negative. None of the cases of Hodgkin's disease and anaplastic large cell lymphoma expressed PKC beta(2). PKC beta(2) expression varies significantly among lymphoproliferative diseases. In our series, the highest level of expression was found in mantle cell lymphomas and chronic lymphocytic lymphoma.Keywords
This publication has 10 references indexed in Scilit:
- The Role of Protein Kinase C-Alpha in Hematologic MalignanciesActa Haematologica, 2006
- Inhibition of Protein Kinase C beta by Enzastaurin (LY 317615) Induces Alterations of Key Regulators of Cell Cycle and Apoptosis in Mantle Cell Lymphoma and Synergizes with Chemotherapeutic Agents in a Sequence Dependent Manner.Blood, 2005
- Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphomaLaboratory Investigation, 2005
- PKCθ mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemiaOncogene, 2004
- Characterization of expression of protein kinase C isozymes in human B‐cell lymphoma: Relationship between its expression and prognosisPathology International, 2004
- A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase CThe Hematology Journal, 2002
- PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signalingNature Immunology, 2002
- Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learningNature Medicine, 2002
- Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of CancerCurrent Drug Targets, 2000
- Immunodeficiency in Protein Kinase Cβ-Deficient MiceScience, 1996